** Shares of medical equipment maker West Pharmaceutical Services WST.N fall 14.01% to $277.13 premarket
** Co sees 2025 adj profit between $6 and $6.20 per share, missing analysts avg estimate of $7.44 per share - LSEG
** Sees 2025 sales between $2.88 bln and $2.91 bln, below estimates of $3.04 bln
** Posts Q4 adj profit of $1.82 per share vs analysts avg estimate of $1.72 per share
** Posts Q4 sales of $748.8 mln vs analysts avg estimate of $740.47 mln
** In the last 12 months, WST has fallen ~21%
(Reporting by Siddhi Mahatole)
((Siddhiprabhanjan.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.